Who we are?
New company, new name, but lots of familiar faces. Our team began working together at Diagnostic Systems Laboratories (DSL) where we enjoyed 25 years of developing novel assays, exploring new biomarkers with key opinion leaders, developing intellectual property, and building relationships with our customers around the world. Over the years, our team of experts has developed some of the most challenging hormone assays helping to advance clinical diagnostics in reproductive function. Today, at Ansh Labs, we are back in the lab and developing the next generation of immunoassays for endocrinology research and diagnostics.
What we do?
Ansh Labs develops and manufactures tools for biomedical research and clinical diagnostics. We serve life science researchers, physician researchers, hospitals, commercial laboratories, and public health agencies to assist with the research, diagnosis, treatment, and management of diseases. The products we develop make it possible to conduct important research in various clinical diagnostic areas.
Our scientists and advisors are experts in immunoassay development. We excel at developing immunoassays from concept to fully validated assays. The efficiency of our monoclonal antibody development process enables us to produce and screen more antibodies to optimize pairs for a better immunoassay. Our core strength is research and development. We perform contract development and custom manufacturing services of novel immunoassays and specialty reagents for diagnostics and biotechnology research and discovery.
Our products consist of emerging and maturing assays that are used by translational medicine and preclinical biomarker testing services, as well as clinical labs around the world. Ansh Labs’ core immunoassays are novel research clinical diagnostic markers with potential applications in:
• Reproductive Function
• Central Nervous System
• Atherosclerotic Cardiovascular Disease
• IGF System
• Neurodegenerative Disorders